Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what recent assessment he has made of the implications for his policies of the research undertaken by Gabriella d’Ettorre of the Sapienza University of Rome and others entitled Challenges in the Management of SARS-CoV2 Infection: The Role of Oral Bacteriotherapy as Complementary Therapeutic Strategy to Avoid the Progression of COVID-19, published in Frontiers in Medicine.

The research, undertaken by Gabriella d’Ettorre and others, adds to the evidence on the potential role of probiotics to benefit patients with COVID-19. We will invite the Therapeutic Taskforce’s expert group on prophylaxis to consider the evidence of benefits and risks of probiotic supplementation for COVID-19 patients.